Seer Aktie - SEER

Professionelle Tools für Privatanleger.

Premium

Current Price

2,31

Gebot

2,17

Fragen

9,14

Volumen

218.671

2,28 Tagesbereich 2,365

1,51 52-Wochen-Bereich 2,625

Marktkapitalisierung

136,213M

Handelsende

2,32

Handelsbeginn

2,31

Letzte Trade

2.36

Letzter Handelszeitpunkt

Finanzvolumen

US$ 507.946

VWAP

2,3229

Durchschnittliches Volumen (3 Mio.)

248.586

Ausgegebene Aktien

58.966.560

Dividendenrendite

Kurs-Gewinn-Verhältnis

-1,57

Gewinn pro Aktie (EPS)

-1,46

Erlöse

16,66M

Nettogewinn

-86,28M

Seer Inc is a biotechnology company. The company commercializes transformative products for researchers to unlock deep, unbiased biological information. Its product, the Proteograph Product Suite (Proteograph), will leverage its proprietary engineered nanoparticle (NP) technology to provide unbiased... Seer Inc is a biotechnology company. The company commercializes transformative products for researchers to unlock deep, unbiased biological information. Its product, the Proteograph Product Suite (Proteograph), will leverage its proprietary engineered nanoparticle (NP) technology to provide unbiased, deep, rapid and large-scale access across the proteome. Mehr anzeigen

Sektor

Lab Analytical Instruments

Branche

Lab Analytical Instruments

Website

www.seer.bio

Hauptsitz

Wilmington, Delaware, USA

Gegründet

Seer Inc is listed in the Lab Analytical Instruments sector of the NASDAQ with ticker SEER. The last closing price for Seer was US$2,32. Over the last year, Seer shares have traded in a share price range of US$ 1,51 to US$ 2,625.

Seer currently has 58.966.560 shares in issue. The market capitalisation of Seer is US$136,80 million. Seer has a price to earnings ratio (PE ratio) of -1.57.

Seer Ranked Number 57 Fastest-Growing Company in North America on the 2024 Deloitte Technology Fast 500™

REDWOOD CITY, Calif., Nov. 21, 2024 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced it...

Seer to Participate in Upcoming November Investor Conferences

REDWOOD CITY, Calif., Nov. 08, 2024 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced company...

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Seer Reports Third Quarter 2024 Financial Results

REDWOOD CITY, Calif., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today reported...

Seer Enters into a Co-Marketing and Sales Agreement with Thermo Fisher Scientific

REDWOOD CITY, Calif., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced a...

Seer Highlights Capability of Deep Proteomics to Enhance Genomic Insights Into Alzheimer’s, Lung Cancer, and More at ASHG 2024

REDWOOD CITY, Calif., Oct. 31, 2024 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, will showcase the...

Seer Showcases Scalable Proteomic Advancements Impacting Alzheimer’s, Population Health, and Xenotransplantation at HUPO 2024

REDWOOD CITY, Calif., Oct. 21, 2024 (GLOBE NEWSWIRE) -- Seer, Inc., (Nasdaq: SEER), a leading life science innovator shaping the future of proteomics, is set to present significant advancements...

Seer to Report Third Quarter 2024 Financial Results on November 6, 2024

REDWOOD CITY, Calif., Oct. 17, 2024 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced that...

Form 4 - Statement of changes in beneficial ownership of securities

Zeitraum †	Änderung	Änderung %	Handelsbeginn	Hoch	Niedrig	Durchsch. Volumen	VWAP
1	-0.15	-6.09756097561	2.46	2.52	2.2025	195183	2.36120264	CS
4	-0.07	-2.94117647059	2.38	2.625	2.2025	214082	2.44660862	CS
12	0.46	24.8648648649	1.85	2.625	1.82	248586	2.19740481	CS
26	0.64	38.3233532934	1.67	2.625	1.56	331138	1.91543325	CS
52	0.49	26.9230769231	1.82	2.625	1.51	396961	1.87663866	CS
156	-20.09	-89.6875	22.4	24.66	1.455	376857	5.41875604	CS
260	-45.69	-95.1875	48	86.55	1.455	407540	16.76263382	CS

SEER - Frequently Asked Questions (FAQ)

What is the current Seer share price?

The current share price of Seer is US$ 2,31

How many Seer shares are in issue?

Seer has 58.966.560 shares in issue

What is the market cap of Seer?

The market capitalisation of Seer is USD 136,8M

What is the 1 year trading range for Seer share price?

Seer has traded in the range of US$ 1,51 to US$ 2,625 during the past year

What is the PE ratio of Seer?

The price to earnings ratio of Seer is -1,57

What is the cash to sales ratio of Seer?

The cash to sales ratio of Seer is 8,14

What is the reporting currency for Seer?

Seer reports financial results in USD

What is the latest annual turnover for Seer?

The latest annual turnover of Seer is USD 16,66M

What is the latest annual profit for Seer?

The latest annual profit of Seer is USD -86,28M

What is the registered address of Seer?

The registered address for Seer is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801

What is the Seer website address?

The website address for Seer is www.seer.bio

Which industry sector does Seer operate in?

Seer operates in the LAB ANALYTICAL INSTRUMENTS sector

Volumen
% Tops
% Flops

Symbol	Preis	Vol.
MYSZMy Size Inc	US$ 4,2001 (211,12%)	121,03M
NVNINVNI Group Ltd	US$ 8,26 (209,36%)	78,06M
TPICTPI Composites Inc	US$ 2,45 (100,82%)	34M
ICGIntchains Group Ltd	US$ 8,77 (88,60%)	527,94k
HSDTHelius Medical Technologies Inc	US$ 0,884851 (84,34%)	121,95M
CYNCYNGN Inc	US$ 0,4603 (-71,41%)	27,5M
MTEMMolecular Templates Inc	US$ 0,1502 (-57,09%)	8,63M
PRFXPainReform Ltd	US$ 5,15 (-53,85%)	2,84M
GALTGalectin Therapeutics Inc	US$ 1,03 (-48,50%)	8,58M
BCABBioAtla Inc	US$ 0,6923 (-41,82%)	5,96M
EDBLEdible Garden AG Inc	US$ 0,24 (65,06%)	354,33M
NVDANVIDIA Corporation	US$ 134,70 (3,08%)	310,19M
APTOAptose Biosciences Inc	US$ 0,28 (64,51%)	306,25M
TNXPTonix Pharmaceuticals Holding Corporation	US$ 0,606999 (6,49%)	293,22M
PLTRPalantir Technologies Inc	US$ 80,55 (8,54%)	281,23M

Foren

Foren anzeigen

Keine Diskussionen Gefunden.

Neuen Thread Erstellen

Trends

Toplisten

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

Seer Inc (SEER) Börsenkurse

Seer Inc (SEER)

Professionelle Tools für Privatanleger.

Wichtige Statistiken und Details

Über Seer Inc

SEER Neueste Nachrichten

SEER - Frequently Asked Questions (FAQ)

Beweger

Foren

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen